Amitriptyline absorption in a patient with short bowel syndrome.

Abstract

Oral drug therapy in patients with short bowel syndrome can be quite challenging. We report the case of a 40-yr-old woman with short bowel syndrome and depression requiring antidepressant drug therapy. After buccal administration of amitriptyline, therapeutic serum antidepressant concentrations were attained despite the patient having only 18 inches of proximal small bowel. Clinical improvement in mood was seen, with the only drug side effects being dry mouth and bitter drug taste. Buccal absorption likely is playing a major role in attaining therapeutic serum tricyclic antidepressants drug concentrations.

• Authors: B Robbins, R A Reiss
• Journal: The American journal of gastroenterology (Am J Gastroenterol) Vol. 94 Issue 8 Pg. 2302-4 (Aug 1999) ISSN: 0002-9270 [Print] United States
• PMID: 10445571 (Publication Type: Journal Article)

Chemical References

• Antidepressive Agents, Tricyclic
• Amitriptyline

Topics

• Administration, Oral
• Adult
• Amitriptyline (administration & dosage, adverse effects, pharmacokinetics)
• Antidepressive Agents, Tricyclic (administration & dosage, adverse effects, pharmacokinetics)
• Biological Availability
• Crohn Disease (surgery)
• Depressive Disorder (blood, drug therapy)
• Dose-Response Relationship, Drug
• Female
• Humans
• Intestinal Absorption (physiology)
• Mouth Mucosa (metabolism)
• Short Bowel Syndrome (blood)